Patent · US Expired

Mutants of human antithrombin III

US5618713A · kind A · utility

8Cited by

1References

4Claims

0Family size

Assignee

Behringwerke Aktiengesellschaft · DE

Inventors

Gerd Zettlmeissl · Lahntal, DE
Hermann E. Karges · Marburg, DE
Achim Becker · Darmstadt, DE

Key dates

Filing date	Dec 18, 1992
Grant date	Apr 8, 1997
Priority date	—
Expiry date	Dec 18, 2012

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Mutants of AT III which have been advantageously modified at one or more potential glycosylation sites or at the Arg393 position are described. As a rule, combination of the mutations enhances the advantageous modifications.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.